www.unityscreen.com Open in urlscan Pro
52.17.119.105  Public Scan

Form analysis
0 forms found in the DOM

Text Content

UNITY Fetal RhD NIPT: Stratify which pregnancies may not need Rho(D) immune
globulin Learn More
Close Banner

Skip to Main Content
PatientsProvidersPublicationsAbout
Login

PatientsProviders
Request a Test Kit


UNITY Complete®



THE NEW STANDARD IN PRENATAL CARE.



One blood draw from mom. Multiple, direct genetic insights into baby.


Providers
Request a Test Kit
Request a Test Kit



DISCOVER WHAT SETS UNITY COMPLETE APART.

UNITY Complete Fetal Risk Screen is prenatal screening reimagined. It has earned
a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10
key advancement in applying genomics to clinical care.¹


First-and-only tests


The first and only test that uses cell-free DNA to provide precise fetal
insights for both recessive and chromosomal conditions.

UNITY Complete evaluate the baby’s genetic information, which can be found in
mom’s bloodstream. By doing so, it can determine how likely it is that baby will
be born with specific genetic conditions, even without information from the
baby's father.

The first and only test that uses cell-free DNA to provide precise fetal
insights for both recessive and chromosomal conditions.

UNITY Complete evaluates the baby’s genetic information, which can be found in
mom’s bloodstream. By doing so, it can determine how likely it is that baby will
be born with specific genetic conditions, even without information from the
baby's father.


Reassurance for 99% of pregnancies


With UNITY Fetal Risk Screen, the vast majority of patients will learn that
there is a very low chance their baby will be born with serious recessive
condition, such as Cystic Fibrosis, Spinal Muscular Atrophy, and other
conditions.

This can provide peace of mind and reassurance to more than 99% of pregnancies
tested with UNITY Fetal Risk Screen2.

With UNITY Fetal Risk Screen, the vast majority of patients will learn that
there is a very low chance their baby will be born with serious recessive
conditions, such as Cystic Fibrosis, Spinal Muscular Atrophy, or other
conditions.

This can provide peace of mind and reassurance to more than 99% of pregnancies
tested with UNITY Fetal Risk Screen.2



Testing of father not needed


Unlike other genetic testing options, UNITY Complete does not rely on a male
partner sample for an informative result. This is different from traditional
carrier screening, which relies on information from the baby's father.

Unlike other genetic testing options, UNITY Complete does not rely on the father
for an informative result. This is different from traditional carrier screening,
which relies on information from the baby's father.






KNOW MORE. KNOW EARLY.



Identifying potential genetic conditions at the earliest stages is not just
about preparation, it's about empowerment.


EARLY INTERVENTION



UNITY Complete provides early detection of severe genetic conditions, early in a
pregnancy. Knowing early allows access to timely interventions and treatments.


INFORMED DECISIONS



Knowledge is empowerment. You and your healthcare team can make informed and
confident decisions about your care and management.


PEACE OF MIND



99% of patients will learn there is a low chance that a baby will be born with
certain genetic conditions2.


PREPARATION FOR PARENTHOOD



Early insights enable you to prepare for the emotional, mental, and practical
considerations for your new baby.


TAKE THE NEXT STEP WITH UNITY COMPLETE.





Whether you are a provider looking to order your first UNITY Complete test, or
an expectant parent wanting to know more, we are here to support your journey.


Request a Test Kit


PROVIDERS

Learn about the tests, access peer-reviewed publications, and more

Get Provider Information


PATIENTS

Learn more about what to expect with UNITY Complete

Get Patient Information


REFERENCES

 1. 1. Teri A. Manolio, et al. Genomic medicine year in review: 2023, The
    American Journal of Human Genetics, Volume 110, Issue 12, Pages 1992-1995,
    https://doi.org/10.1016/j.ajhg.2023.11.001.

 2. 2. Wynn J, et al. Performance of single-gene noninvasive prenatal testing
    for autosomal recessive conditions in a general population setting. Prenat
    Diagn. 2023 Sep; 43(10):1344-1354. doi: 10.1002/pd.6427. Epub 2023 Sep 6.
    PMID: 37674263

UNITY Logo
by Billion To One

+1 (650) 460-2551
support@unityscreen.com
AboutPatientsProvidersPublicationsLogin
Facebook

X

LinkedIn




1035 O’Brien Drive, Menlo Park, CA 94025 © 2016 – 2024 BillionToOne Inc. All
rights reserved. BillionToOne® Registered in U.S. Patent and Trademark Office

Privacy PolicyNotice of Privacy Practices